Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

Claudio Coco; Gian Franco Zannoni; Emanuele Caredda; Stefano Sioletic; Alma Boninsegna Lucarelli; Mario Migaldi; Gianluca Rizzo; Luca Reggiani Bonetti; Giannicola Genovese; Egidio Stigliano; Achille Renato Maria Cittadini; Alessandro Sgambato

doi:10.1186/1756-9966-31-71

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

Claudio Coco, Gian Franco Zannoni, Emanuele Caredda, Stefano Sioletic, Alma Boninsegna Lucarelli, Mario Migaldi, Gianluca Rizzo, Luca Reggiani Bonetti, Giannicola Genovese, Egidio Stigliano, Achille Renato Maria Cittadini, Alessandro Sgambato

University of Modena and Reggio Emilia

Research output: Contribution to journal › Article

44 Citations (Scopus)

Abstract

Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.

Original language	English
Pages (from-to)	71-71
Number of pages	1
Journal	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume	31
DOIs	https://doi.org/10.1186/1756-9966-31-71
Publication status	Published - 2012

Keywords

CD133
colon cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/1756-9966-31-71

Cite this

Coco, C., Zannoni, G. F., Caredda, E., Sioletic, S., Boninsegna Lucarelli, A., Migaldi, M., Rizzo, G., Bonetti, L. R., Genovese, G., Stigliano, E., Cittadini, A. R. M., & Sgambato, A. (2012). Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 31, 71-71. https://doi.org/10.1186/1756-9966-31-71

@article{2716961456f342c39df59cb87cbb22aa,

title = "Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients",

abstract = "Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.",

keywords = "CD133, colon cancer, CD133, colon cancer",

author = "Claudio Coco and Zannoni, {Gian Franco} and Emanuele Caredda and Stefano Sioletic and {Boninsegna Lucarelli}, Alma and Mario Migaldi and Gianluca Rizzo and Bonetti, {Luca Reggiani} and Giannicola Genovese and Egidio Stigliano and Cittadini, {Achille Renato Maria} and Alessandro Sgambato",

year = "2012",

doi = "10.1186/1756-9966-31-71",

language = "English",

volume = "31",

pages = "71--71",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "0392-9078",

publisher = "Attuale:APSIT ASSOC PROM STUD IMMUNOL TUMOR, VIALE REGINA ELENA 291, ROME, ITALY, 00161 Centro Ricerca Sperimentale:Via Delle Messi d Oro 156, 00158 Rome Italy:011 39 06 52662536, EMAIL: journal@ifo.it, INTERNET: http://crs.ifo.it, Fax: 011 39 06 52662505",

}

Coco, C , Zannoni, GF, Caredda, E, Sioletic, S, Boninsegna Lucarelli, A, Migaldi, M, Rizzo, G, Bonetti, LR, Genovese, G, Stigliano, E, Cittadini, ARM & Sgambato, A 2012, 'Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients', JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol. 31, pp. 71-71. https://doi.org/10.1186/1756-9966-31-71

TY - JOUR

T1 - Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

AU - Coco, Claudio

AU - Zannoni, Gian Franco

AU - Caredda, Emanuele

AU - Sioletic, Stefano

AU - Boninsegna Lucarelli, Alma

AU - Migaldi, Mario

AU - Rizzo, Gianluca

AU - Bonetti, Luca Reggiani

AU - Genovese, Giannicola

AU - Stigliano, Egidio

AU - Cittadini, Achille Renato Maria

AU - Sgambato, Alessandro

PY - 2012

Y1 - 2012

N2 - Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.

AB - Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.

KW - CD133

KW - colon cancer

KW - CD133

KW - colon cancer

UR - http://hdl.handle.net/10807/40235

U2 - 10.1186/1756-9966-31-71

DO - 10.1186/1756-9966-31-71

M3 - Article

SN - 0392-9078

VL - 31

SP - 71

EP - 71

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

ER -

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this